Viewing nowBielpe Tablet 10mg (Donepezil Hydrochloride Hydrate)
Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
CL Pharm Co., Ltd.

MFDS item code 202005299 · Approved 2020.07.23 · Insurance code 622600450
Treatment of symptoms of Alzheimer-type dementia
This medication is used to treat symptoms of Alzheimer’s-type dementia. It helps alleviate key symptoms such as memory impairment and cognitive decline, aiding patients in improving their daily life. Positive effects are expected in slowing the progression of symptoms and maintaining quality of life.
○ Adults: Administer donepezil hydrochloride 5 mg once daily at bedtime. If sleep disturbances such as abnormal dreams, nightmares, or insomnia occur, morning administration of this medicine may be considered. Because donepezil concentrations reach steady state 15 days after administration and the incidence of adverse reactions may be affected by the rate of dose escalation, administer the 5 mg dose for 4~6 weeks. After assessing the clinical response during this period, the dose may be increased to 10 mg. When increasing the dose to 10 mg daily, administer with attention to gastrointestinal adverse reactions. If treatment with this medicine is discontinued, its effects gradually diminish; no rebound effect occurs with abrupt discontinuation. ○ Female patients aged 85 years and older with low body weight: Careful monitoring is necessary because adverse reactions occur more frequently. Elderly women with low body weight should not exceed 5 mg daily.
○ Children: There is no experience with use in children.
This medication should not be used by patients who are allergic to certain ingredients or who have hypersensitivity to Donepezil Hydrochloride or piperidine derivatives. It is advisable for women who are pregnant, may become pregnant, or are breastfeeding to avoid taking this medicine. Patients with genetic problems such as lactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption should not take this medicine. Patients with heart disease or cardiac conduction disorders should be cautious as this medication may cause heart problems like bradycardia or arrhythmias. Patients taking non-steroidal anti-inflammatory drugs or with a history of peptic ulcers should use this medication cautiously, as it may increase gastric acid secretion and gastrointestinal motility, worsening their symptoms. Patients with a history of asthma or obstructive pulmonary disease should also be careful, as this medication may increase bronchoconstriction and mucus secretion, worsening their symptoms. Patients with extrapyramidal disorders such as Parkinson’s disease should take this medication with careful monitoring as it may worsen their symptoms. This medication contains Yellow No. 5 dye, so it should be administered cautiously to patients with hypersensitivity or a history of allergy to it. If serious side effects such as syncope, bradycardia, heart block, gastrointestinal bleeding, liver dysfunction, cerebrovascular disorders, movement disorders, or neuroleptic malignant syndrome occur, discontinue use immediately and seek medical attention. This medication may cause various side effects such as nausea, vomiting, diarrhea, dizziness, insomnia, hallucinations, depression, and cardiac arrhythmias, so if symptoms are severe or persistent, consult a doctor. The effectiveness for other memory impairments apart from dementia has not been established, so it should only be used for patients with Alzheimer’s-type dementia, and discontinuation should be considered if no therapeutic effect is observed. Patients with cardiovascular diseases may experience abnormalities in heart rhythm upon taking this medication, requiring regular ECG monitoring. As this medication may affect driving or machinery operation, caution is needed during the initial stages of treatment or when changing doses. There are many potential interactions with other drugs, so particular attention should be paid to changes in efficacy when taken with medications that inhibit or induce CYP3A4 or CYP2D6. Pregnant or breastfeeding women should avoid this medication, and if it must be taken, it is recommended to discontinue breastfeeding. Safety in children has not been established, so it is not used in children. In cases of overdose, serious symptoms such as nausea, vomiting, respiratory depression, and bradycardia may arise, necessitating immediate medical treatment; atropine may be used as an antidote. This medication should be kept out of reach of children and should not be transferred to other containers.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent air and moisture from entering and is best kept at room temperature between 1 and 30 degrees Celsius. Storing it this way can help maintain the effectiveness of the medication.
Yellow round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowDonepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
CL Pharm Co., Ltd.

Donepezil Hydrochloride 5mg
Tablet · Prescription medication
HanDoc Co., Ltd.

Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Hanmi Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
IYun Pharmaceuticals Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Yuhan Corporation

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
Myungmoon Pharmaceutical Co., Ltd.

Donepezil Hydrochloride Hydrate 10.43mg
Tablet · Prescription medication
HK inno.N Co., Ltd.
Donepezil Hydrochloride 10mg
Tablet · Prescription medication
Celltrion Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.